- In February 2022, Databricks introduced the Databricks Lakehouse for Healthcare and Life Sciences, a unified analytics platform designed to combine data management, artificial intelligence, and analytics in one solution. This platform enables tasks such as disease prediction, biomarker discovery, and medical image analysis to be conducted more efficiently. By consolidating capabilities into a single system, it improves workflow speed and analytical precision. The launch strengthens Databricks’ role in digital healthcare transformation, driving innovation across research and clinical domains. This advancement is expected to boost the adoption of AI-driven insights in the life sciences market
- In July 2022, Charles River Associates launched the Healthcare Claims Analytics Platform (HCAP) during the World Orphan Drug Congress in Boston. This platform uses machine learning and patient analytics to deliver deep insights into healthcare claims data. It enables pharmaceutical and healthcare organizations to make more informed strategic decisions based on predictive modelling. The introduction of HCAP enhances real-time understanding of market trends and patient needs. This development is expected to accelerate evidence-based decision-making and improve healthcare outcomes across various therapeutic areas
